XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net loss $ (15,263,388) $ (16,911,361)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 571,859 668,908
Stock-based compensation expense 1,455,493 3,070,892
Common stock issued for financial advisory services 135,000
Change in fair value of acquisition contingencies (727,289) (206,144)
Non-cash lease expense (2,003) 10,613
Realized gain on investments (641,823) (302,235)
Loss from equity method investment 15,204 145,458
(Gain) loss on disposition of assets 9,004 (3,500)
Provision for (recoveries of) credit losses (13,248) (40,944)
Inventory obsolescence expense (recovery) (95,302) 84,430
Changes in assets and liabilities:    
Accounts receivable (65,150) (206,634)
Prepaid expenses and other assets 690,010 299,970
Inventory 83,399 116,335
Deferred revenue 5,000 (141,519)
Income taxes payable 23,290 39,927
Accounts payable, accrued expenses and other liabilities (3,213,100) (318,728)
Net cash used in operating activities (17,033,044) (13,694,532)
Cash flows from investing activities    
Purchases of property and equipment (492,973) (500,922)
Proceeds from maturities of marketable investment securities 31,509,485 26,836,743
Purchases of marketable securities (6,588,577) (13,699,301)
Net cash provided by investing activities 24,427,935 12,636,520
Cash flows from financing activities    
Issuance of common stock related to at-the-market offering, net of offering costs 783,746
Net cash provided by financing activities 783,746
Net increase (decrease) in cash and cash equivalents 8,178,637 (1,058,012)
Cash and cash equivalents at beginning of period 2,936,544 14,916,878
Cash and cash equivalents at end of period 11,115,181 13,858,866
Supplemental disclosure of cash flow information    
Income taxes paid $ 800